Beacon Pointe Advisors’s ResMed RMD Stock Holding History

Beacon Pointe Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,277	Closed	-$511K	–	2019
2026 Q1	$511K	Buy	+2,277	New	+$567K	﹤0.01%	1290
2024 Q3	–	Sell	-3,631	Closed	-$695K	–	1299
2024 Q2	$695K	Sell	3,631 -340	-9%	-$69K	0.01%	752
2024 Q1	$786K	Buy	+3,971	New	+$728K	0.01%	758
2023 Q3	–	Sell	-970	Closed	-$212K	–	1349
2023 Q2	$212K	Buy	+970	New	+$216K	﹤0.01%	992
2022 Q4	–	Sell	-936	Closed	-$205K	–	1099
2022 Q3	$205K	Buy	+936	New	+$213K	﹤0.01%	925
2022 Q2	–	Sell	-978	Closed	-$237K	–	1190
2022 Q1	$237K	Buy	+978	New	+$237K	﹤0.01%	1065
2021 Q4	–	Sell	-847	Closed	-$223K	–	991
2021 Q3	$223K	Sell	847 -2	-0.2%	-$547	0.01%	817
2021 Q2	$209K	Buy	+849	New	+$178K	0.01%	785

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Beacon Pointe Advisors's RMD Position: Q2 2026 in Review

Beacon Pointe Advisors sold out of ResMed (RMD) in Q2 2026, closing a stake of 2,277 shares — an estimated $511K sold.

Beacon Pointe Advisors first reported a position in RMD in Q2 2021 and held it in 8 quarters. The position peaked at $786K in Q1 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Beacon Pointe Advisors reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Beacon Pointe Advisors sold 2,277 ResMed shares in Q2 2026, an estimated $511K.
Beacon Pointe Advisors first reported a position in ResMed in Q2 2021 and held it in 8 quarters.
Beacon Pointe Advisors's ResMed position peaked at $786K in Q1 2024.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.